Pheochromocytoma and Paraganglioma Susceptibility Genes: Estimating the Associated Risk of Disease

Lauren Fishbein¹, Katherine L Nathanson^{2

3}

Affiliations

¹ Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora.
² Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
³ Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.

Comment

Lauren Fishbein et al. JAMA Oncol. 2017.

. 2017 Sep 1;3(9):1212-1213.

doi: 10.1001/jamaoncol.2017.0222.

Lauren Fishbein¹, Katherine L Nathanson^{2

3}

¹ Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora.
² Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
³ Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.

No abstract available

Comment on

Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
Bausch B, Schiavi F, Ni Y, Welander J, Patocs A, Ngeow J, Wellner U, Malinoc A, Taschin E, Barbon G, Lanza V, Söderkvist P, Stenman A, Larsson C, Svahn F, Chen JL, Marquard J, Fraenkel M, Walter MA, Peczkowska M, Prejbisz A, Jarzab B, Hasse-Lazar K, Petersenn S, Moeller LC, Meyer A, Reisch N, Trupka A, Brase C, Galiano M, Preuss SF, Kwok P, Lendvai N, Berisha G, Makay Ö, Boedeker CC, Weryha G, Racz K, Januszewicz A, Walz MK, Gimm O, Opocher G, Eng C, Neumann HPH; European-American-Asian Pheochromocytoma-Paraganglioma Registry Study Group. Bausch B, et al. JAMA Oncol. 2017 Sep 1;3(9):1204-1212. doi: 10.1001/jamaoncol.2017.0223. JAMA Oncol. 2017. PMID: 28384794 Free PMC article.